Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Perspective Therapeutics
CATX
$327M
| $15.5M | 0.01% |
+1,308,948
| New | +$11.2M |
|
|
BWIN
602
Baldwin Insurance Group
BWIN
$2.75B
| $15.4M | 0.01% |
531,927
-133,552
| -20% | -$3.51M |
|
603
HubSpot
HUBS
$12.9B
| $15.4M | 0.01% |
24,521
+689
| +3% | +$414K |
|
604
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $15.3M | 0.01% |
195,847
-14,798
| -7% | -$1.15M |
|
605
Envista
NVST
$4.62B
| $15.1M | 0.01% |
707,275
-1,161,171
| -62% | -$26.3M |
|
|
SP
606
DELISTED
SP Plus Corporation
SP
| $15.1M | 0.01% |
289,789
+39,871
| +16% | +$2.06M |
|
607
Kyverna Therapeutics
KYTX
$430M
| $15M | 0.01% |
+606,500
| New | +$16.9M |
|
608
Alphatec Holdings
ATEC
$1.48B
| $15M | 0.01% |
1,090,680
-329,013
| -23% | -$4.88M |
|
609
NewAmsterdam Pharma
NAMS
$3.26B
| $15M | 0.01% |
+636,231
| New | +$12.9M |
|
610
Alamos Gold
AGI
$12B
| $15M | 0.01% |
1,015,071
-60,219
| -6% | -$761K |
|
|
ENFN
611
DELISTED
Enfusion, Inc.
ENFN
| $15M | 0.01% |
1,616,458
-19,303
| -1% | -$170K |
|
612
Ceco Environmental
CECO
$3.49B
| $14.9M | 0.01% |
647,990
-7,559
| -1% | -$156K |
|
613
Embecta
EMBC
$218M
| $14.9M | 0.01% |
1,119,353
-626,784
| -36% | -$9.71M |
|
|
FNA
614
DELISTED
Paragon 28, Inc.
FNA
| $14.8M | 0.01% |
1,199,819
+273,077
| +29% | +$3.25M |
|
615
New Oriental
EDU
$9.32B
| $14.4M | 0.01% |
165,873
-1,752
| -1% | -$149K |
|
616
Cadeler
CDLR
$2.04B
| $14.4M | 0.01% |
792,218
+410,148
| +107% | +$7.23M |
|
617
Pinduoduo
PDD
$126B
| $14.3M | 0.01% |
123,039
-12,860
| -9% | -$1.68M |
|
618
Cigna
CI
$78.4B
| $14.2M | 0.01% |
39,178
-900
| -2% | -$296K |
|
619
Royal Bank of Canada
RY
$287B
| $14.2M | 0.01% |
140,296
-4,976
| -3% | -$491K |
|
620
CVS Health
CVS
$135B
| $14.1M | 0.01% |
177,372
+4,318
| +2% | +$330K |
|
621
Cogent Biosciences
COGT
$6.76B
| $14.1M | 0.01% |
2,099,357
+2,083,065
| +12,786% | +$12.9M |
|
622
Nicolet Bankshares
NIC
$3.6B
| $14.1M | 0.01% |
163,919
+157,566
| +2,480% | +$12.6M |
|
623
Illinois Tool Works
ITW
$84.1B
| $13.9M | 0.01% |
51,969
+12,051
| +30% | +$3.13M |
|
624
DoubleVerify
DV
$1.77B
| $13.9M | 0.01% |
396,111
+335,197
| +550% | +$12.5M |
|
625
Lamb Weston
LW
$7.42B
| $13.8M | 0.01% |
129,995
-2
| -0% | -$208 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.